3 February 2022 - The European Union's drug regulator said on Thursday it would support a filing for approval of an upgraded COVID-19 vaccine targeting only the new Omicron variant if that is the quickest way to broaden the offering of available shots.

Speaking to journalists in a briefing, the European Medicines Agency's head of vaccines strategy, Marco Cavaleri, reiterated that he encouraged pharmaceuticals companies to explore not only a monovalent shot tailored to the Omicron variant but also versions that address a combination of variants.

Read Reuters article